Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Theravance Biopharma, Inc. - Ordinary Shares (NQ:TBPH)

14.75 -0.12 (-0.81%)
Streaming Delayed Price Updated: 4:00 PM EST, Nov 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 263,792
Open 14.87
Bid (Size) 13.80 (1,000)
Ask (Size) 15.54 (100)
Prev. Close 14.87
Today's Range 14.51 - 15.00
52wk Range 7.900 - 15.34
Shares Outstanding 49,471,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
PACCAR Posts Downbeat Earnings, Joins Neuphoria Therapeutics, Citius Pharmaceuticals And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
 
Via Benzinga
Why Crown Holdings Shares Are Trading Higher By Around 9%; Here Are 20 Stocks Moving Premarket
 
Via Benzinga

Performance

YTD
+58.9%
+58.9%
1 Month
+5.4%
+5.4%
3 Month
+29.4%
+29.4%
6 Month
+67.6%
+67.6%
1 Year
+62.4%
+62.4%

More News

Read More
Theravance Biopharma Launches Disease Education Campaign to Advance Scientific Understanding of Neurogenic Orthostatic Hypotension Due to Multiple System Atrophy
From Theravance Biopharma
Via Business Wire
Earnings Scheduled For May 8, 2025
Via Benzinga
Earnings Scheduled For February 26, 2025
Via Benzinga
Earnings Scheduled For November 12, 2024
Via Benzinga
Unveiling 4 Analyst Insights On Theravance Biopharma
Via Benzinga
This Protagonist Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 3 Initiations For Friday
Via Benzinga
Theravance Sales Jump 83 Percent
Via The Motley Fool
Theravance Biopharma Inc (NASDAQ:TBPH) Misses Q2 2025 Revenue and EPS Estimates Amid Mixed Market Reaction
Via Chartmill
Topics Earnings
This Coinbase Global Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Tuesday
Via Benzinga
Cracking The Code: Understanding Analyst Reviews For Theravance Biopharma
Via Benzinga
Recap: Theravance Biopharma Q4 Earnings
Via Benzinga
A Preview Of Theravance Biopharma's Earnings
Via Benzinga
Earnings Scheduled For August 12, 2025
Via Benzinga
TBPH Stock Earnings: Theravance Biopharma Beats EPS, Misses Revenue for Q2 2024
Via InvestorPlace
Mama's Creations, GameStop And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Via Benzinga
Sidoti Events, LLC's Virtual June Small-Cap Conference
Via ACCESSWIRE
TBPH Stock Earnings: Theravance Biopharma Beats EPS, Beats Revenue for Q1 2024
Via InvestorPlace
BTIG Research Predicts Over 118% Rally for These 3 Stocks
Via InvestorPlace
Short-Squeeze Showdown: 3 Stocks Ready to Crush the Skeptics
Via InvestorPlace
Earnings Scheduled For February 26, 2024
Via Benzinga
Logitech Posts Q3 Results, Joins Coinbase And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Topics Stocks
Why Applied Therapeutics Shares Are Trading Lower By Over 35%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Why Is Lung Disease Focused Theravance Biopharma Stock Trading Lower Today?
Via Benzinga

Frequently Asked Questions

Is Theravance Biopharma, Inc. - Ordinary Shares publicly traded?
Yes, Theravance Biopharma, Inc. - Ordinary Shares is publicly traded.
What exchange does Theravance Biopharma, Inc. - Ordinary Shares trade on?
Theravance Biopharma, Inc. - Ordinary Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Theravance Biopharma, Inc. - Ordinary Shares?
The ticker symbol for Theravance Biopharma, Inc. - Ordinary Shares is TBPH on the Nasdaq Stock Market
What is the current price of Theravance Biopharma, Inc. - Ordinary Shares?
The current price of Theravance Biopharma, Inc. - Ordinary Shares is 14.75
When was Theravance Biopharma, Inc. - Ordinary Shares last traded?
The last trade of Theravance Biopharma, Inc. - Ordinary Shares was at 11/07/25 04:00 PM ET
What is the market capitalization of Theravance Biopharma, Inc. - Ordinary Shares?
The market capitalization of Theravance Biopharma, Inc. - Ordinary Shares is 729.70M
How many shares of Theravance Biopharma, Inc. - Ordinary Shares are outstanding?
Theravance Biopharma, Inc. - Ordinary Shares has 730M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.